Lastly, and more speculative as the role of IL-17 in atherosclerosis is controversially discussed, CXCL4 might influence atherosclerosis by limiting Th17-dependent inflammatory processes as CXCL4 was shown to limit Th17 differentiation (Shi et al., 2014). This evidence concerns the gene PF4 and atherosclerosis.